Regular use alongside balanced nutrition and exercise may support overall energy metabolism
Implications for practice Iatrogenic cough is said to occur in at least 10% of people using an ACE inhibitor, although in clinical practice, anecdotally, it feels as if it is more common
In a phase 2 trial, people with T2D and overweight/obesity achieved greater mean WL with cagrisema 2.4 mg compared to cagrilintide 2.4 mg or semaglutide 2.4 mg alone after 32 weeks of treatment (15.6% WL vs
A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral semaglutide, made by Novo Nordisk, suggests the former pill may have the edge in reducing blood sugar and weight
Some services (like Spark Healthcare) may offer competitive pricing due to reduced overhead costs associated with virtual clinics